Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROTECT-APT 1
NCT05954286Phase 2Completed
- Sponsor
- Henry M. Jackson Foundation for the Advancement of Military Medicine
- Start
- Jan 2024
- Primary completion
- Apr 2025
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of upamostat in coronavirus disease 2019 (COVID-19), sponsored by Henry M. Jackson Foundation for the Advancement of Military Medicine. Started Jan 2024; status: completed.
02
Drugs
upamostat
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05954286.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05954286.